Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine in Elderly Subjects With Psychosis
NCT00281320Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of asenapine in psychosis (2 arms), sponsored by Organon & Co. Primary endpoints: Number of Participants Who Experienced an Adverse Event, Number of Participants Who Discontinued Because of an Adverse Event and 6 more. Started Feb 2006; status: completed.
02
Drugs
asenapine
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT00281320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281320.